Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
42 studies found for:    stroke AND san diego | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting E-Rehabilitation: Aerobic Resistance Training for Stroke Survivors
Conditions: Stroke;   Hemiplegia
Interventions: Device: Theraband with exercise video;   Other: usual care with advice to exercise
2 Recruiting Calibrating Cardiac Output Measurement of Electrical Cardiometry With Transthoracic Echocardiography
Condition: Coronary Artery Disease
Interventions: Other: passive leg raising test;   Procedure: right heart catheterisation;   Other: TTE vs. EC + calibration group
3 Recruiting Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Condition: Carotid Stenosis
Interventions: Procedure: Carotid endarterectomy;   Device: Carotid stenting
4 Recruiting Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke
Condition: Acute Ischemic Stroke
Interventions: Drug: natalizumab;   Drug: Placebo
5 Recruiting Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
Conditions: Stroke;   Secondary Prevention
Interventions: Drug: optional ASA as comedication;   Drug: placebo to ASA;   Drug: placebo to optional ASA as comedication;   Drug: placebo to dabigatran etexilate;   Drug: ASA 100 mg;   Drug: dabigatran etexilate
6 Recruiting ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab
Condition: Acute Coronary Syndrome
Interventions: Drug: alirocumab;   Drug: Placebo
7 Recruiting Cardiovascular Inflammation Reduction Trial
Condition: Cardiovascular Disease
Interventions: Drug: Methotrexate;   Drug: Placebo
8 Recruiting A Novel Healthcare Information Technology Tool to Improve Care in Patients With Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention:
9 Recruiting Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Conditions: Cancer Survivor;   Cardiovascular Complication;   Malignant Childhood Neoplasm
Interventions: Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration
10 Recruiting Post Market Surveillance Study of the Wingspan Stent System
Condition: Intracranial Atherosclerosis
Intervention: Device: Wingspan Stent System
11 Recruiting Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus
Interventions: Biological: Albiglutide 30 mg;   Biological: Albiglutide 50 mg;   Biological: Albiglutide matching placebo
12 Recruiting GLORIA-AF Registry Program - Second and Third Phases
Conditions: Stroke;   Atrial Fibrillation
Intervention:
13 Recruiting Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities
Condition: Peripheral Artery Disease
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban-Placebo
14 Recruiting Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis
Condition: Anemia
Interventions: Drug: Roxadustat;   Drug: Placebo
15 Not yet recruiting A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: semaglutide;   Drug: placebo
16 Recruiting Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation
Conditions: Ventricular Tachycardia;   Atrial Fibrillation
Interventions: Drug: Ethanol;   Procedure: Ablation
17 Recruiting BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Intervention: Biological: botulinum toxin Type A
18 Recruiting BOTOX® Treatment in Pediatric Upper Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Interventions: Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
19 Recruiting Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Condition: Anaemia
Interventions: Drug: Daprodustat;   Drug: Darbepoetin alfa;   Drug: Placebo;   Drug: Iron Therapy
20 Recruiting Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)
Condition: Anaemia
Interventions: Drug: Daprodustat;   Drug: rhEPO;   Drug: Placebo;   Drug: Iron therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.